Thomas Flaten
Stock Analyst at Lake Street
(4.49)
# 1,115
Out of 4,692 analysts
350
Total ratings
49.9%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals | Maintained: Buy | $9 | $5.46 | +64.84% | 1 | Aug 28, 2026 | |
| PSNL Personalis | Maintained: Hold | $16 | $16.78 | -3.16% | 32 | Aug 21, 2026 | |
| EVAX Evaxion | Maintained: Buy | $9 | $3.00 | +200.00% | 26 | Aug 21, 2026 | |
| HROW Harrow | Maintained: Buy | $60 | $36.91 | +62.56% | 20 | Aug 20, 2026 | |
| AEON AEON Biopharma | Maintained: Buy | $1 | $0.2959 | +237.95% | 2 | Aug 19, 2026 | |
| IMDX Insight Molecular Diagnostics | Maintained: Buy | $12 | $3.92 | +206.12% | 26 | Aug 18, 2026 | |
| AQST Aquestive Therapeutics | Maintained: Buy | $6 | $5.11 | +17.42% | 37 | Aug 10, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $7 | $1.52 | +360.53% | 9 | Aug 10, 2026 | |
| BLFS BioLife Solutions | Maintained: Hold | $31 | $37.07 | -16.37% | 27 | Aug 7, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $52 → $57 | $33.03 | +72.57% | 25 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $2.20 | +309.09% | 3 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.35 | +120.47% | 23 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $2.29 | +205.68% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $5 | $0.7202 | +594.25% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $7.41 | +75.44% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $13.15 | +82.51% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $26.35 | +51.83% | 14 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $7.94 | +38.54% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $24.08 | +107.64% | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.60 | n/a | 15 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 | $0.0001 | n/a | 8 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 → $15 | $0.3927 | n/a | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $1.70 | n/a | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $50 | $43.19 | n/a | 4 | Mar 1, 2022 |
Verrica Pharmaceuticals
Aug 28, 2026
Maintained: Buy
Price Target: $9
Current: $5.46
Upside: +64.84%
Personalis
Aug 21, 2026
Maintained: Hold
Price Target: $16
Current: $16.78
Upside: -3.16%
Evaxion
Aug 21, 2026
Maintained: Buy
Price Target: $9
Current: $3.00
Upside: +200.00%
Harrow
Aug 20, 2026
Maintained: Buy
Price Target: $60
Current: $36.91
Upside: +62.56%
AEON Biopharma
Aug 19, 2026
Maintained: Buy
Price Target: $1
Current: $0.2959
Upside: +237.95%
Insight Molecular Diagnostics
Aug 18, 2026
Maintained: Buy
Price Target: $12
Current: $3.92
Upside: +206.12%
Aquestive Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $6
Current: $5.11
Upside: +17.42%
Rapid Micro Biosystems
Aug 10, 2026
Maintained: Buy
Price Target: $7
Current: $1.52
Upside: +360.53%
BioLife Solutions
Aug 7, 2026
Maintained: Hold
Price Target: $31
Current: $37.07
Upside: -16.37%
Castle Biosciences
Jul 31, 2026
Maintained: Buy
Price Target: $52 → $57
Current: $33.03
Upside: +72.57%
Jul 15, 2026
Maintained: Buy
Price Target: $9
Current: $2.20
Upside: +309.09%
Jun 23, 2026
Reiterated: Buy
Price Target: $14
Current: $6.35
Upside: +120.47%
May 14, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $2.29
Upside: +205.68%
May 14, 2026
Maintained: Buy
Price Target: $9 → $5
Current: $0.7202
Upside: +594.25%
May 14, 2026
Maintained: Buy
Price Target: $13
Current: $7.41
Upside: +75.44%
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $13.15
Upside: +82.51%
May 5, 2026
Maintained: Buy
Price Target: $40
Current: $26.35
Upside: +51.83%
Apr 15, 2026
Maintained: Buy
Price Target: $11
Current: $7.94
Upside: +38.54%
Mar 25, 2026
Reiterated: Buy
Price Target: $50
Current: $24.08
Upside: +107.64%
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $9.60
Upside: n/a
Nov 29, 2023
Maintained: Buy
Price Target: $1.5
Current: $0.0001
Upside: n/a
Apr 12, 2023
Maintained: Buy
Price Target: $96 → $15
Current: $0.3927
Upside: n/a
Sep 16, 2022
Maintained: Buy
Price Target: $3.5
Current: $1.70
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $60 → $50
Current: $43.19
Upside: n/a